Icon

DIAMOX (nda008943)- (125MG,250MG)

ACETAZOLAMIDE TEVA BRANDED PHARM
125MG,250MG
No No
Expired Expired
None None
None No
DIAMOX is indicated for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. DIAMOX is also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent.
15 0 11
Total Other Developers None
Drugs with Suitability No
125MG ** ** - - 9
250MG ** ** - - 9
NDA Sales Available Total Generic Sales Available
No 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** **** ************** ********** ***. *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** ******** ****** ******** ****** **** ***. */*/* **** *************** **** ***. *********** *** ******* **, **** *********, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ****** ******* ****** ******* ******* *********** *. *. **. **, **/** *** **/*, **** ****, *************, **********, ********** ******, ***** (***) ***
****** ******** ****** ******** ****** *** *********** ** **** *****, **** *******, *** ****** (**) *****, ****** ****** (***) ***
****** ***** ***** ****** *** *********** *** *** *** ********* ** ***** *, *, *-* & *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ******* ******* ******** ******* ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***
****** ***** ************ ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***
****** ** ** ****** ******* *************** ** *** *********** * ******** ****, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** ****** *** ****** ****** ******* *********** *-*\*\*, **** ****, *******, *********** *************, *********** ******, ***** (***) ***
****** ****** ******** **** ****** ***. *********** * ****** *****, ********, *** ****** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.